
Mayo Clinic
Description
Mayo Clinic, a globally renowned nonprofit academic medical center based in Rochester, Minnesota, extends its mission of patient care, education, and research into the venture capital landscape through Mayo Clinic Ventures. This dedicated arm strategically invests in early-stage companies developing innovative technologies that align with Mayo Clinic's core objectives. Their investment focus spans critical areas such as digital health solutions, advanced medical devices, novel therapeutics, and precision diagnostics, aiming to accelerate the translation of promising research into clinical practice and commercial success.
Mayo Clinic Ventures acts as more than just a capital provider; it offers portfolio companies unparalleled access to Mayo Clinic's vast clinical expertise, research infrastructure, and patient populations. This unique value proposition includes opportunities for clinical validation, scientific collaboration, and strategic guidance from leading medical experts. The team actively seeks out companies that can significantly impact healthcare delivery, improve patient outcomes, and contribute to Mayo Clinic's long-term strategic goals, often co-investing with traditional venture capital firms and corporate partners.
The venture arm has built a substantial portfolio, reportedly comprising over 100 companies across various stages of development, demonstrating its sustained commitment to healthcare innovation. While investment sizes can vary based on the stage and strategic importance of the opportunity, Mayo Clinic Ventures typically provides initial checks ranging from $1 million to $5 million for early-stage companies. These investments are often part of larger syndicated rounds, reflecting their preference for collaborative funding models. Their strategic approach emphasizes long-term partnerships and the potential for significant clinical and commercial impact, rather than purely financial returns.
The strategic investments made by Mayo Clinic Ventures underscore the institution's forward-thinking approach to healthcare innovation. By leveraging its deep clinical and research capabilities, Mayo Clinic not only supports the growth of promising startups but also ensures that cutting-edge technologies are developed and integrated into patient care, ultimately benefiting a broader population and reinforcing its leadership in medical advancement.
Investor Profile
Mayo Clinic has backed more than 88 startups, with 5 new investments in the last 12 months alone. The firm has led 13 rounds, about 15% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in United States, Israel, Canada.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (27%)
- Series B (24%)
- Seed (18%)
- Series Unknown (8%)
- Series C (8%)
- Series D (5%)
- Corporate Round (3%)
- Convertible Note (3%)
- Pre Seed (1%)
- Non Equity Assistance (1%)
Country Focus
- United States (85%)
- Israel (3%)
- Canada (2%)
- Sweden (1%)
- India (1%)
- Switzerland (1%)
- South Korea (1%)
- China (1%)
- United Kingdom (1%)
- The Netherlands (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Artificial Intelligence (Ai)
- Software
- Health Diagnostics
- Medical Device
- Therapeutics
- Pharmaceutical
- Machine Learning
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.